Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference

Chemed Corporation (NYSE: CHE), based in Cincinnati, Ohio, has announced its participation in the upcoming UBS 2025 Global Healthcare Conference, scheduled for November 11, 2025. The presentation will take place at approximately 2:00 p.m. ET at the PGA National Resort in Palm Beach Gardens, Florida. Investors and interested parties will be able to access a live webcast of the presentation, along with accompanying materials, through the Chemed website under the Investor Relations section. A replay of the webcast will be available within 24 hours of the event and can be accessed for a period of 90 days.

Chemed operates two key wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare is recognized as the largest provider of end-of-life hospice care in the United States, offering compassion and comprehensive services to patients and their families during critical times. Roto-Rooter, on the other hand, stands out as the leading provider of plumbing and drain cleaning services nationwide, known for its reliability and commitment to customer satisfaction.

The press release also includes a cautionary note regarding forward-looking statements, which may relate to potential future events or performance outcomes for the company. These statements are based on current information and existing business conditions, but come with inherent risks that could lead to actual results differing materially from projections. Investors are advised that Chemed does not commit to updating any forward-looking statements in response to unforeseen events or changes in expectations.

For additional inquiries, Michael D. Witzeman can be contacted at (513) 762-6714. Investors and stakeholders are encouraged to note this upcoming presentation, as it will provide valuable insights into Chemed's strategic direction and business performance.

As Chemed Corporation (NYSE: CHE) approaches its presentation at the UBS 2025 Global Healthcare Conference, it is crucial for investors to examine the company's positioning and the implications for its stock performance. With two major businesses—VITAS Healthcare and Roto-Rooter—Chemed operates in the growing sectors of hospice care and essential home services, respectively.

VITAS Healthcare stands to benefit from an aging population, which is driving demand for hospice care services. As healthcare costs continue to rise, patients increasingly prefer in-home care options that cater to their personal and family needs. This trend enhances VITAS's growth potential, as it positions itself as the leading provider in a sector that is witnessing increasing public and governmental support.

On the other hand, Roto-Rooter's plumbing and drain cleaning services provide stability and consistent revenue even during economic downturns. Home maintenance services are often viewed as essential, providing Chemed a robust revenue stream regardless of broader market fluctuations.

As an investor, it is essential to keep an eye on Chemed's ability to navigate potential challenges and capitalize on opportunities within these sectors. Market sentiments suggest that as healthcare reforms evolve and consumer preferences shift towards quality and at-home services, Chemed's integrated approach could yield positive outcomes.

However, investors should remain cautious. Chemed's forward-looking statements indicate the inherent risks involved in its operations. Economic uncertainties, competitive pressures, and regulatory changes could impact future performance.

Overall, with careful monitoring of market trends and company announcements, Chemed Corporation presents a blended investment opportunity characterized by both growth and stability. The presentation at the UBS conference should provide further insights into strategic initiatives and financial outlook, which will be essential for making informed investment decisions.